4.8 Review

Cancer Stemness Meets Immunity: From Mechanism to Therapy

期刊

CELL REPORTS
卷 34, 期 1, 页码 -

出版社

CELL PRESS
DOI: 10.1016/j.celrep.2020.108597

关键词

-

资金

  1. NIH [R01 CA231360, R00 CA240896, P50CA221747, P01 CA117969, R01 CA225955]
  2. Cancer Research Institute Irvington Postdoctoral Fellowship
  3. Harter Prize
  4. Caroline Ross Endowed Fellowship
  5. Harold C. and Mary L. Daily Endowment Fellowship
  6. Burkhart III Distinguished University Chair in Cancer Research Endowment

向作者/读者索取更多资源

This review explores the symbiotic interactions between cancer stem cells and immune cells, highlighting the importance of tumor-associated macrophages, myeloid-derived suppressor cells, and T cells in maintaining CSC stemness and survival niche. It also discusses therapeutic strategies targeting this co-dependency to disrupt tumor-promoting ecosystems.
Cancer stem cells (CSCs) are self-renewing cells that facilitate tumor initiation, promote metastasis, and enhance cancer therapy resistance. Transcriptomic analyses acrossmany cancer types have revealed a prominent association between stemness and immune signatures, potentially implying a biological interaction between such hallmark features of cancer. Emerging experimental evidence has substantiated the influence of CSCs on immune cells, including tumor-associated macrophages, myeloid-derived suppressor cells, and T cells, in the tumor microenvironment and, reciprocally, the importance of such immune cells in sustaining CSC stemness and its survival niche. This review covers the cellular and molecular mechanisms underlying the symbiotic interactions between CSCs and immune cells and how such heterotypic signaling maintains a tumor-promoting ecosystem and informs therapeutic strategies intercepting this co-dependency.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据